Physicians have launched the world’s first mRNA lung cancer vaccine trial, marking a significant advancement in cancer treatment.
BioNTech developed the vaccine BNT116, which targets non-small cell lung cancer (NSCLC) by training the immune system to identify and attack tumor markers.
Conducted across seven countries, including Türkiye, the phase 1 trial involves 130 patients with varying stages of lung cancer and aims to eliminate cancer cells and prevent recurrence.
The trial uses mRNA technology similar to that in COVID-19 vaccines, potentially offering a less toxic alternative to traditional chemotherapy.
Experts view this trial as a groundbreaking step in cancer research, with the first patient in the UK receiving the vaccine recently.
Source : PhilNews24 | August 24, 2024
WORLD’S INITIAL LUNG CANCER VACCINE TRIAL KICKS OFF
You might be interested in
Latest from News
The Marcos administration has allocated an additional P5 billion to expand public WiFi hotspots in public
Two new impeachment complaints were filed with the House of Representatives against Vice President Sara Duterte,
President Ferdinand Marcos Jr. led an interagency meeting to discuss preparations for the Philippines’ hosting of
Rare earths, essential to products such as electric vehicles, wind turbines, hard drives, and missiles,s are
The government plans to spend P1.4 billion in the first quarter of 2026 to support economic